Generated by AI
Biodesix, Inc. is a diagnostic solutions company focused on blood-based testing and development services for lung disease, with a strong emphasis on lung cancer care. Biodesix provides commercial tests such as Nodify XL2 and Nodify CDT for lung nodule risk assessment, along with GeneStrat ddPCR, GeneStrat NGS, and VeriStrat to support diagnostic and treatment decisions in oncology. The company also serves biopharmaceutical, life sciences, and diagnostic partners with services that include biomarker discovery, assay design, clinical trial sample testing, regulatory support, reimbursement support, commercialization, and logistics. By combining laboratory diagnostics with research and development capabilities, Biodesix plays a specialized role in precision medicine and respiratory health, helping clinicians and industry customers address unmet needs in lung-related disease management.
Website919 West Dillon Road
Louisville, CO, 80027
United States
The latest articles about BDSX.
Summary of Feb 26's posts. Generated by AI.
Summary of Jan 21's posts. Generated by AI.
Summary of Feb 2's posts. Generated by AI.
Summary of Feb 26's posts. Generated by AI.
Investors talking about BDSX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.